Started the national rectification of medical representatives.

On August 10, according to the National Health and Wellness Commission, the 22nd meeting of the Inter-ministerial Joint Meeting on Correcting The Wrong Winds in the Field of Pharmaceutical Purchase and Sale and Medical Services was held in Beijing recently.
meeting, the whole supervision of pharmaceutical supplies, regulate medical practice behavior, combat fraud insurance, rectify the operation order of the industry and other work is summarized and deployed. the
meeting called for the 2020 anti-wind work to continue to crack down on fraudulent fraud to defraud medical insurance funds, consolidate the effectiveness of the drug circulation field, resolutely clean up the industry chaos, the national health system and provincial wind control mechanism member units responsible for comrades and other nearly 3000 people through the video system to attend the meeting.
August 4, the website of the State Supervision Commission of the Central Commission for Discipline Inspection published "Focus areas positive wind anti-corruption observation deep investigation of medical corruption", said that the medical field resolutely investigated and punished serious violations of discipline.
article shows that in the first half of this year disclosed in the medical field corruption cases, the collection of drug supplies rebates is the most frequent problem, the amount involved in the case remains high, the chain of corrupt interests is chained together.
Since this year, discipline inspection and supervision organs at all levels have adhered to in-depth investigations by industry sub-sectors, in-depth rectification of corruption and style of work in the medical field, august to December nationwide to carry out anti-unfair competition enforcement actions in key areas, crack down on pharmaceutical rebates, catch typical, purify the industry atmosphere.
check insulation (two-vote, one-vote...) What are the main points of correcting the wrong trend in the field of pharmaceutical purchase and sale and medical services in 2020? Cypress blue equipment according to the document combed as follows: the program pointed out that will strengthen the management of pharmaceutical production and circulation.
to promote the implementation of the drug distribution industry development plan, establish and improve the responsibility system for safe production.
particular emphasis will be placed on the pharmaceutical production and circulation of the field of bills behavior to be strictly investigated.
need to point out that the pharmaceutical industry has been a mess, the state has been on the pharmaceutical enterprise sales costs of authenticity, compliance, pharmaceutical enterprises sales link to carry out "penetrating" supervision.
The State Council Medical Reform Office and other ministries have jointly issued the "on the implementation of the "two-vote system" in the procurement of drugs in public medical institutions", requiring medical institutions in the drug inspection revenue bank, must verify the ticket, goods, accounts of the three consistent before storage, use.
Not only to the distribution of drugs circulation enterprises to request, verify invoices, but also should require the circulation enterprises to issue stamped copies of the purchase invoices provided by the production enterprises, two invoices of the drug circulation enterprise name, drug batch number and other related content mutually confirmed, and as a public medical institutions to pay for drugs vouchers, into the financial file management.
means that the "two-vote system" requires that only up to two invoices be issued from production to use, i.e. up to one level of reseller.
, the reduction of the number of bills has become inevitable, the authenticity of bills will be further standardized, the state is targeted supervision.
inspection of pharmaceutical representatives sales program pointed out that will strictly regulate the way of cooperation and exchanges between medical businessmen.
the bottom line of behavior between trade associations, medical institutions and pharmaceutical-related enterprises, and formulate norms of behavior for medical personnel's foreign contacts.
(screenshot source: National Health and Wellness Commission) crack down on misconduct by using academic conferences, scientific collaboration, academic support, and donations to fund the transfer of benefits.
allows medical and commercial exchanges to be carried out under the premise of compliance and legality, and establishes and improves the whole process management system of pre-publicity, in-process supervision and post-filing of exchanges and cooperation between the two sides.
of the current health care reform measures, are in the elimination of gold sales.
now there are a lot of first-line medical representatives after perception, think that as long as the doctor has a private desire, will certainly be able to rely on rebates to find a way out, still cling to the disability.
On June 5, the State Drug Administration publicly solicited the opinions of the Measures for the Administration of the Filing of Pharmaceutical Representatives (Trial) (Draft for Comments), which, in order to implement the Notice issued by the General Office of the Central Committee of the Communist Party of China and the General Office of the State Council on the Deepening of the Reform of the Review and Approval System to Encourage the Innovation of Pharmaceutical Medical Devices, to regulate the practice of pharmaceutical representatives.
medical representatives in the work, some red lines must not be touched. The
Measures state that drug market license holders shall not have the following circumstances: encouraging or implying that pharmaceutical representatives engage in illegal and illegal activities, assigning drug sales tasks to pharmaceutical representatives, requiring pharmaceutical representatives to collect and process purchase and sale bills, and pharmaceutical representatives shall not carry out academic promotion activities without the consent of medical institutions;
inspection of pharmaceutical representatives to the rebate program pointed out that the collection of pharmaceutical supplies enterprise rebate behavior will be seriously investigated.
to carry out special governance to combat the collection of kickbacks by medical institutions practitioners, and to investigate and punish medical institutions and medical personnel for seeking improper benefits and receiving kickbacks by using their practice.
(Screenshot Source: National Health and Safety Commission) focuses on examining the practice of medical institutions practitioners receiving rebates in various names and forms from employees of medical institutions in the production, operation or distribution of pharmaceutical products such as medicines, medical devices and medical hygiene materials.
The medical personnel who have been investigated shall be dealt with seriously in accordance with the law and in accordance with the rules, and the illegal clues of the rebates given to the operators of the pharmaceutical products involved shall be handed over to the market regulatory authorities, and the enterprises involved in the administrative punishment shall be made public through the credit information publicity system of the state enterprises.
to explore the establishment of enterprise credit evaluation and punishment mechanism.
(screenshot source: National Health and Safety Commission) from the time process can be seen, the medical representative of the violation of the law is increasingly strong.
prohibit pharmaceutical sales representatives from entering the medical service area to engage in commercial promotion activities.
according to the announcement of a number of hospitals combed the punishment for the illegal promotion of pharmaceutical representatives, agent drug supplies deactivation is a relatively common means, the current promotion of pharmaceutical representatives put forward requirements.
Pharma must see this trend clearly, with gold sales undoubtedly contrary to the direction of policy-driven, and hospitals to shut it out is inevitable, how to promote compliance has become a matter for pharmaceutical representatives to think about.
.